fda warning bpc-157 compounding pharmacies advisory committee votes to add popular peptide to drug list An FDA panel will consider

An FDA panel will consider whether to allow compounding pharmacies to manufacture certain peptides. Here's what to know about their safety and efficacy. The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline What's behind the push to make peptide therapies more readily available : NPR BPC 157: Miracle Healing Peptide or Hidden Danger?

SKU: 6646793749 · From lagence-mr.com